The SSRI antidepressant paroxetine may have a place in the management of persistent cough in patients with advanced cancer, Australian research suggests. A small retrospective study of 34 patients from the Peter MacCallum Cancer Centre has found most (71%) experienced a resolution of cough or reduction in cough severity with off-label paroxetine. Almost half the ...
Already a member?
Enter your email to keep reading.